Physician profile
Daniel Hakimi
NPI 1033160890
$6,203.85
in general payments reported to CMS, 2019-2025
10 companies · $5,692 in 2025
The $5,692 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $140 · 2021: $91.81 · 2022: $31.84 · 2024: $118 · 2025: $5,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,599 · Travel and Lodging: $1,186 · Food and Beverage: $25.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,599.00 |
| Travel and Lodging | $1,186.08 |
| Food and Beverage | $25.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,692.47 | 2025 | |
| Abbvie INC. | $172.03 | 2019-2021 | |
| Astellas Pharma US INC | $117.65 | 2024 | Veozah |
| Myovant Sciences INC. | $84.06 | 2021-2022 | |
| Therapeuticsmd, INC. | $38.41 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $32.33 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $26.17 | 2019-2020 | |
| Daiichi Sankyo INC. | $13.81 | 2021 | |
| Covidien Lp | $13.59 | 2020 | |
| Lupin INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hakimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.